The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Apr. 24, 2018
Filed:
May. 28, 2015
Applicant:
Benjamin M. Yu, Plainfield, IL (US);
Inventor:
Benjamin M. Yu, Plainfield, IL (US);
Assignee:
SPRAYABLE HOLDINGS, INC., Dover, DE (US);
Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/185 (2006.01); A61K 31/195 (2006.01); A61K 31/21 (2006.01); A61K 31/739 (2006.01); A61K 31/4045 (2006.01); A61K 47/22 (2006.01); A61K 31/385 (2006.01); A61K 31/355 (2006.01); A61K 31/59 (2006.01); A61K 38/06 (2006.01); A61K 31/05 (2006.01); A61K 31/122 (2006.01); A61K 31/015 (2006.01); A61K 31/07 (2006.01); A61K 31/375 (2006.01); A61K 31/714 (2006.01); A61K 31/675 (2006.01); A61K 31/519 (2006.01); A61K 31/145 (2006.01); A61K 47/18 (2017.01); A61K 9/00 (2006.01); A61K 47/10 (2017.01); A61K 9/08 (2006.01); A61K 9/12 (2006.01);
U.S. Cl.
CPC ...
A61K 31/4045 (2013.01); A61K 9/0014 (2013.01); A61K 9/08 (2013.01); A61K 9/12 (2013.01); A61K 31/015 (2013.01); A61K 31/05 (2013.01); A61K 31/07 (2013.01); A61K 31/122 (2013.01); A61K 31/145 (2013.01); A61K 31/185 (2013.01); A61K 31/355 (2013.01); A61K 31/375 (2013.01); A61K 31/385 (2013.01); A61K 31/519 (2013.01); A61K 31/59 (2013.01); A61K 31/675 (2013.01); A61K 31/714 (2013.01); A61K 38/063 (2013.01); A61K 47/10 (2013.01); A61K 47/18 (2013.01); A61K 47/183 (2013.01); A61K 47/22 (2013.01); A61K 9/0043 (2013.01);
Abstract
One aspect of the invention relates to AI-helper compositions comprising an AI compound (e.g., melatonin) and one or more helper esters. The AI-helper compositions disclosed herein can be used for effective transdermal delivery of the AI compound to a subject. Another aspect of the invention relates to applications and preparations of the AI-helper compositions.